Extended treatment with bupropion SR for cigarette smoking cessation

Journal of Consulting and Clinical Psychology

Volumn 74, Issue 2, 2006, Pages 286-294

  Killen, Joel D ^a   Fortmann, Stephen P ^a   Murphy Jr , Greer M ^a   Hayward, Chris ^a   Arredondo, Christina ^a   Cromp, DeAnn ^a   Celio, Maria ^a   Abe, Laurie ^a   Wang, Yun ^a   Schatzberg, Alan F ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bupropion SR; Extended treatment; Nicotine dependence; Smoking cessation

Indexed keywords

AMFEBUTAMONE; NICOTINE PATCH; PLACEBO;

ABNORMAL DREAMING; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; EDEMA; FEMALE; HEADACHE; HEART ARRHYTHMIA; HUMAN; HYPERTHYROIDISM; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; RANDOMIZED CONTROLLED TRIAL; RASH; RELAPSE; SEIZURE; SEX DIFFERENCE; SLEEP DISORDER; SMOKING CESSATION; SMOKING CESSATION PROGRAM; TACHYCARDIA; THROMBOCYTOPENIC PURPURA; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; BUPROPION; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; SMOKING; SMOKING CESSATION;

EID: 33744468794     PISSN: 0022006X     EISSN: None     Source Type: Journal    
DOI: 10.1037/0022-006X.74.2.286     Document Type: Article

References (48)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
2. Anda, R. F., Williamson, D. F., Escobedo, L. G., Mast, E. E., Giovino, G. A., & Remington, P. L. (1990). Depression and the dynamics of smoking: A national perspective. JAMA, 264, 1541-1545.
3. Breslau, N., Kilbey, M. M., & Andreski, P. (1991). Nicotine dependence, major depression, and anxiety in young adults. Archives of General Psychiatry, 48, 1069-1074.
4. Doherty, K., Kinnunen, T., Militello, F. S., & Garvey, A. J. (1995). Urges to smoke during the first month of abstinence: Relationship to relapse and predictors. Psychopharmacology, 119, 171-178.
5. Durcan, M. J., Deener, G., White, J., Johnston, J. A., Gonzalez, D., Niaura, R., et al. (2002). The effect of bupropion sustained-release on cigarette craving after smoking cessation. Clinical Therapeutics, 24, 540-551.
6. Fagerström, K. O. (1978). Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addictive Behaviors, 3, 235-241.
7. Fiore, M. C., Smith, S. S., Jorenby, D. E., & Baker, T. B. (1994). The effectiveness of the nicotine patch for smoking cessation. JAMA, 271, 1940-1947.
8. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1997). Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), clinician's version. Washington, DC: American Psychiatric Press.
9. Fleiss, J. L. (1981). Statistical methods for rates and proportions. New York: Wiley.
10. Foulds, J., Burke, M., Steinberg, M., Williamson, J. M., & Ziedonis, D. M. (2004). Advances in pharmacotherapy for tobacco dependence. Expert Opinion on Emerging Drugs, 9, 39-53.
11. George, T. P., & O'Malley, S. S. (2004). Current pharmacological treatments for nicotine dependence. Trends in Pharmacologic Sciences, 25, 42-48.
12. Gilbert, H. M., & Warburton, D. M. (2002). Attribution and the effects of expectancy: How beliefs can influence the experiences of smoking cessation. Addictive Behaviors, 874, 1-11.
13. Glassman, A. H., Heizer, J. E., Covey, L. S., Cottler, L. B., Stetner, F., Tipp, J. E., & Johnson, J. (1990). Smoking, smoking cessation, and major depression. JAMA, 264, 1546-1549.
14. Gourlay, S. G., Forbes, A., Marriner, T., Pethica, D., & McNeil, J. J. (1994). Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. British Medical Journal, 309, 842-846.
15. Greenhouse, J. B., Stangl, D., Kupfer, D. J., & Prien, R. F. (1991). Methodologic issues in maintenance therapy clinical trials. Archives of General Psychiatry, 48, 313-318.
16. Hall, S. M., Humfleet, G. L., Reus, V. I., Munoz, R. F., & Cullen, J. (2004). Extended nortriptyline and psychological treatment for cigarette smoking. American Journal of Psychiatry, 161, 2100-2107.
17. Hall, S. M., Humfleet, G. L., Reus, V. I., Munoz, R. F., Hartz, D. T., & Maude-Griffin, R. (2002). Psychological intervention and antidepressant treatment in smoking cessation. Archives of General Psychiatry, 59, 929-937.
18. Hall, S. M., Tunstall, C., Rugg, D., Jones, R. T., & Benowitz, N. (1985). Nicotine gum and behavioral treatment in smoking cessation. Journal of Consulting and Clinical Psychology, 53, 256-258.
19. Hays, J. T., Hurt, R. D., Rigotti, N. A., Niaura, R., Gonzalez, D., Durcan, M. J., et al. (2001). Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. Annals of Internal Medicine, 135, 423-433.
20. Hughes, J. R., Gust, S. W., Keenan, R. M., Fenwick, J. W., & Healey, M. L. (1989). Nicotine vs. placebo gum in general medical practice. JAMA, 261, 1300-1305.
21. Hughes, J. R., Keely, J., & Naud, S. (2004). Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction, 99, 29-38.
22. Hughes, J. R., Keely, J. P., Niaura, R. S., Ossip-Klein, D. J., Richmond, R. L., & Swan, G. E. (2003). Measures of abstinence in clinical trials: Issues and recommendations. Nicotine and Tobacco Research, 5, 13-25.
23. Hurt, R. D., Krook, J. E., Croghan, I. T., Loprinzi, C. L., Sloan, J. A., Novotny, P. J., et al. (2003). Nicotine patch therapy based on smoking rate followed bupropion for prevention of relapse to smoking. Journal of Clinical Oncology, 21, 914-920.
24. Hurt, R. D., Sachs, D. P. L., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., et al. (1997). A comparison of sustained-release bupropion and placebo for smoking cessation. New England Journal of Medicine, 337, 1195-1202.
25. Irvin, J. E., & Brandon, T. H. (2003). Examining a quarter century of smoking cessation trials: Is the target becoming harder to treat? In Those who continue to smoke: Is achieving abstinence harder and do we need to change our interventions? (NIH Pub. No. 03-5370: Smoking and Tobacco Control Monograph 15). Bethesda, MD: National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services.
26. Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., et al. (1999). A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. New England Journal of Medicine, 340, 685-691.
27. Killen, J. D., & Fortmann, S. P. (1997). Craving is associated with smoking relapse: Findings from three prospective studies. Experimental and Clinical Psychopharmacology, 5, 137-142.
28. Killen, J. D., Fortmann, S. P., Telch, M. J., & Newman, B. (1988). Are heavy smokers different from light smokers? A comparison after 48 hours without cigarettes. JAMA, 260, 1581-1585.
29. Killen, J. D., Maccoby, N., & Taylor, C. B. (1984). Nicotine gum and self-regulation training for smoking relapse prevention. Behavior Therapy, 15, 234-248.
30. Kozak, J., Fagerström, K. O., & Sawe, U. (1995). High-dose treatment with the nicotine patch. International Journal of Smoking Cessation, 4, 26-28.
31. Moye, L. A. (2001). Random research. Circulation, 1003, 3150-3153.
32. O'Brien, C. P., & McLellan, A. T. (1996). Myths about the treatment of addiction. Lancet, 347, 237-240.
33. Ockene, J. K., Emmons, K. M., & Mermelstein, R. J. (2000). Relapse and maintenance issues for smoking cessation. Health Psychology, 19(Suppl.), 17-31.
34. Ossip-Klein, D. J., Bigelow, G., Curry, S., Hall, S., & Kirkland, S. (1986). Task Force I. Classification and assessment of smoking behavior: Proceedings of the National Working Conference on Smoking Relapse. Health Psychology, 5, 3-11.
35. Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401.
36. Russell, M. A. H. (1988). Nicotine replacement: The role of blood nicotine levels: Their rate of change and nicotine tolerance. In O. F. Pomerleau & C. S. Pomerleau (Eds.), Nicotine replacement: A critical evaluation (pp. 63-94). New York: Liss.
37. Sachs, D. P. L., Sawe, U., & Leischow, S. J. (1993). Effectiveness of a 16-hr transdermal nicotine patch in a medical practice setting, without intensive group counseling. Archives of Internal Medicine, 153, 1881-1890.
38. Schneider, N., & Jarvik, M. E. (1984). Time course of smoking withdrawal symptoms as a function of nicotine replacement. Psychopharmacology, 82, 143-144.
39. Shiffman, S. (1979). The tobacco withdrawal syndrome. In N. A. Krasnegor (Ed.), Cigarette smoking as a dependence process (NIDA Research Monograph 23). Washington, DC: U.S. Department of Health, Education, and Welfare.
40. Shiffman, S. (1993). Smoking cessation treatment: Any progress? Journal of Consulting and Clinical Psychology, 61, 718-722.
41. Shiffman, S., Engberg, J., Paty, J., Perz, W. G., Gnys, M., Kassel, J., & Hickcox, M. (1997). A day at a time: Predicting smoking lapse from daily urge. Journal of Abnormal Psychology, 106, 104-116.
42. Shiffman, S., Johnston, J. A., Khayrallah, M., Elash, C. A., Gwaltney, C. J., Paty, J. A., et al. (2000). The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology, 148, 33-40.
43. Silagy, C., Mant, D., Fowler, G., & Lodge, M. (1994). Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet, 34, 139-142.
44. Swan, G. E., Ward, M. M., & Jack, L. M. (1996). Abstinence effects as predictors of 28-day relapse in smokers. Addictive Behaviors, 21, 481-490.
45. Tonnesen, P., Paoletti, P., Gustavsson, G., Russell, M. A., Saracci, R., Gulsvik, A., et al. (1999). Higher dosage nicotine patches increase one-year smoking cessation rates: Results from the European CEASE trial (Collaborative European Anti-Smoking Evaluation, European Respiratory Society). European Respiratory Journal, 13, 238-246.
46. West, R. J., & Schneider, N. (1987). Craving for cigarettes. British Journal of Addiction, 82, 407-415.
47. Wetter, D. W., Kenford, S. L., Smith, S. S., Fiore, M. C., Jorenby, D. E., & Baker, T. B. (1999). Gender differences in smoking cessation. Journal of Consulting and Clinical Psychology, 67, 555-562.
48. Wise, R. A. (1988). The neurobiology of craving: Implications for the understanding and treatment of addiction. Journal of Abnormal Psychology, 97, 118-132.